SECAUCUS, N.J., Nov. 14, 2022 /PRNewswire/ — Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced …
Company to host conference call and webcast on November 15, 2022 at 8:00am ET BOSTON and ATLANTA, Nov. 14, 2022 …
SILVER SPRING, Md., Nov. 14, 2022 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an update on …
FREMONT, Calif., Nov. 14, 2022 /PRNewswire/ — THINK Surgical, a technology innovator developing orthopedic surgical robots, today announced the implementation …
SUNNYVALE, Calif., Nov. 1, 2022 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY) announced today that the registration dossier for the CNNC-Accuray …
WALTHAM, Mass. and DUBLIN, Oct. 27, 2022 /PRNewswire/ — Q32 Bio, a clinical stage biotechnology company developing biologic therapeutics to …
Physicians across Europe will now have access to DZUVEO®, a novel sublingual approach to acute pain management in medically supervised …
SOUTH SAN FRANCISCO, Calif., Oct. 27, 2022 /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its …
CAMBRIDGE, Mass., Oct. 27, 2022 /PRNewswire/ — Obsidian Therapeutics, Inc., a clinical-stage biotechnology company pioneering engineered cell and gene therapies, …
Akebia to Host Conference Call to Provide Business Update CAMBRIDGE, Mass., Oct. 27, 2022 /PRNewswire/ — Akebia Therapeutics, Inc. (Nasdaq: AKBA), …
